Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2021 Jan 7;27(3):262.e1–262.e11. doi: 10.1016/j.jtct.2021.01.004

Figure 3. Shannon diversity of the gut microbiome across chlorhexidine gluconate usage groups and stool collection time points.

Figure 3.

Stool samples were obtained for a subset of patients in the study (n=105 patients, 205 samples) and subjected to 16S rRNA gene sequencing. CHG usage groups are designated by number (High CHG=1, Medium CHG=2, Low CHG=3, No CHG=4). Group 1 (High CHG) diversity was higher at days 15-30 compared to Group 4 (p=0.032) although Shannon diversity was not consistently different between patients based on CHG usage.